Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 100 u - muscle relaxants

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 50 u - muscle relaxants

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 200 u - muscle relaxants

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sunward pharmaceutical sdn. bhd. - clostridium botulinum toxin type a -

Australia - English - Department of Health (Therapeutic Goods Administration)

ipsen pty ltd - clostridium botulinum type a toxin haemagglutinin complex, quantity: 500 u - injection, powder for - excipient ingredients: albumin; lactose monohydrate - dysport is indicated for symptomatic treatment of focal spasticity of: ? upper limbs in adults ? lower limbs in adults ? upper limbs in children aged 2 years and older ? lower limbs in children aged 2 years and older,dysport is indicated in adults for the treatment of: ? spasmodic torticollis ? blepharospasm ? hemifacial spasm ? moderate to severe glabellar lines and / or lateral canthal lines (crow?s feet)

Australia - English - Department of Health (Therapeutic Goods Administration)

ipsen pty ltd - clostridium botulinum type a toxin haemagglutinin complex, quantity: 125 u - injection, powder for - excipient ingredients: albumin; lactose monohydrate - dysport is indicated for symptomatic treatment of focal spasticity of: ? upper limbs in adults ? lower limbs in adults ? upper limbs in children aged 2 years and older ? lower limbs in children aged 2 years and older,dysport is indicated in adults for the treatment of: ? spasmodic torticollis ? blepharospasm ? hemifacial spasm ? moderate to severe glabellar lines and / or lateral canthal lines (crow?s feet)

Australia - English - Department of Health (Therapeutic Goods Administration)

ipsen pty ltd - clostridium botulinum type a toxin haemagglutinin complex, quantity: 300 u - injection, powder for - excipient ingredients: albumin; lactose monohydrate - dysport is indicated for symptomatic treatment of focal spasticity of: ? upper limbs in adults ? lower limbs in adults ? upper limbs in children aged 2 years and older ? lower limbs in children aged 2 years and older,dysport is indicated in adults for the treatment of: ? spasmodic torticollis ? blepharospasm ? hemifacial spasm ? moderate to severe glabellar lines and / or lateral canthal lines (crow?s feet)

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 100 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 50 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - clostridium botulinum toxin type a -